Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Liver Cirrhosis
- Hydroxynidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
- A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
- A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
- Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
- DOAC in Patients With Child B Liver Cirrhosis
- Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis
- Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Allopurinol and Quality of Life
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis
- Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments
- A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
- A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
- Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
- Empagliflozin in Patients With Cirrhosis and Ascites
- Effect of Branched-chain Amino Acids (BCAA) to Muscle Cramps in Patients With Cirrhosis
- To Study the Hemodynamic Response of Early Addition of Carvedilol to Terlipressin in Acute Variceal Bleed in Child's B and C Cirrhosis
- COffee and Metabolites Modulating the Gut MicrobiomE in coloN canCER
- Synbiotics Interventions for Managing Cirrhosis and Its Complications
- Opioid Sparing Anesthesia in Patients With Liver Cirrhosis Undergoing Liver Resection
- Coagulation in Cirrhosis
- Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding
- Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
- Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes
- HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes
- Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
- Allopurinol to Prevent Cirrhosis Related Morbidities
- Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
- Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
- Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis
- Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease
- A Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis
- Single Dose Escalation of PHIN-214 in Child-Pugh A Liver Cirrhotics
- Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
- Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
- Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
- 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension
- A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis
- HRS-AKI Treatment With TIPS in Patients With Cirrhosis
- Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
- Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
- A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
- Different Doses of ZED1227 vs. Placebo in NAFLD
- To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
- Growth Hormone in Decompensated Liver Cirrhosis
- Probiotics and Hemodynamic Changes in Cirrhosis
- Effect of Imatinib in Advance Liver Fibrosis Patients
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
- To Study the Safety and Efficacy of Simvastatin in Patients With Hepatopulmonary Syndrome in Cirrhosis.
- Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286
- Composition for Treating Cirrhosis and Liver Cancer (SB-1121)
- Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B
- Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
- Hydronidone for the Treatment of Liver Fibrosis Associated With Chronic Viral Hepatitis B Phase 3 Trial.
- Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
- Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.
- A Trial to Improve Quality of Life in People With Cirrhosis
- To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
- Efficacy and Safety of Carvedilol in Cirrhosis Patients With Uncomplicated Ascites Without High Risk Esophageal Varices
- Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
- Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
- Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
- Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen
- Extension Study of Carvedilol RCT Study
- Empagliflozin in Diuretic Refractory Ascites
- Efficacy of Simvastatin in Alcoholic Liver Fibrosis
- Study of Obeticholic Acid(OCA) Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
- Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)
- Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation
- Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
- A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia
- Danazol for Treatment of Cytopenias in Patients With Cirrhosis
- Study in Healthy Adults Evaluating PF-07202954
- A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis
- Avatrombopaq In Patients With Cirrhosis
- Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock.
- Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.
- Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment
- Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
- Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
- Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
- The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.
- Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension
- Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV With Hemophilia.
- Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
- Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects
- HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
- Angiotensin 2 for AKI After OLT
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 Diabetes
- A Study of EDP-297 in Healthy Subjects
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis
- 68Ga-FAPI PET/CT in Liver Fibrosis Patients
- Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Compensated Liver Cirrhosis
- Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.
- Tranexamic Acid for Acute Upper Gastrointestinal Bleed in Cirrhosis
- A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects
- Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial
- To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.
- Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
- Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
- Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.
- Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
- Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding
- Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.
- Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
- Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
- Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
- A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
- Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)
- HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
- Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
- Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis
- Prophylactic Antibiotics in Admitted Cirrhotics
- Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patients
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis
- Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
- Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis
- Erlotinib for Hepatocellular Carcinoma Chemoprevention
- Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis
- Antibiotic Prophylaxis in Patients Undergoing GVO
- Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation
- A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites
- Ivabradine in Cirrhotic Cardiomyopathy
- Pirfenidone and Advanced Liver Fibrosis.
- A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis
- Rifamycin in Minimal Hepatic Encephalopathy
- Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
- Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
- Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.
- Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis
- Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites
- A Study of Oryz-Aspergillus Enzyme and Pancreatin Tablet in Patients With Cirrhosis and Malnutrition
- Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
- Sorafenib PK in Patients With Advanced HCC and Child-Pugh B
- Plasma Exchange in Acute on Chronic Liver Failure
- Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis
- Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
- Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.
- Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs
- Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients
- Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis
- Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis
- Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis
- GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT
- The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial
- OCR002-SP103 - Oral Immediate Release Study
- To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis
- A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)
- FMT in Cirrhosis and Hepatic Encephalopathy
- Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development
- Beta-blockers for Oesophageal Varices
- Effect of Some Drugs on Liver Fibrosis
- N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial
- Carvedilol for Prevention of Esophageal Varices Progression
- MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
- The Tolerability,Safety,PK/PD Study of rhTPO in the Patients With Liver Function Impairment
- Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR
- An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis
- Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis
- Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
- Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
- Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
- Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
- Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
- First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis
- Management of Decompensated HCV Cirrhotic Patients
- Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis
- A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
- A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
- Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites
- Safety, Tolerability and Pharmacodynamics of SYNB1020
- A Study of Experimental Medication BMS-986036 Given to Healthy Participants
- Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
- A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
- G-CSF in Decompensated Cirrhosis: an Open Label Trial
- Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis
- Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
- Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients?
- In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
- Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis
- Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunode
- Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
- Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
- Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
- Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
- PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
- The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices
- Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction
- To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
- Oral Fecal Transplant in Cirrhosis
- Simvastatin Plus Rifaximin in Decompensated Cirrhosis
- Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis
- Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis
- Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis
- Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue
- Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis
- Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites
- Ramelteon for Treatment of Insomnia in Cirrhosis
- A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis
- Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis
- Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
- Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV
- AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
- PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
- Anticoagulation for Advanced Cirrhotic Patients After TIPS
- Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis
- Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
- Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension
- Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
- Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics
- Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
- FDGal PET/CT to Detect Hepatocellular Carcinoma
- Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.
- Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
- TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
- Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients
- Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction
- Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease
- A Follow-up Evaluation Study of PRI-724-1101
- Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
- Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
- The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter
- Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis
- A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
- Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis
- Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
- Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients
- The Effect of Carvedilol VS Endoscopic Therapy in Primary Prophylaxis of High-risk Esophageal Gastric Variceal Bleeding
- [18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer
- Serelaxin To Lower Portal Pressure
- Multicenter Prospective Randomized Trial of the Effect of Rivaroxaban on Survival and Development of Complications of Portal Hypertension in Patients With Cirrhosis
- Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients
- Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis
- Gabapentin in Treatment of Muscle Cramps in Patients With Liver Cirrhosis
- A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
- To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis
- The Effect of Hepatic Vein Pressure Gradient(HVPG)-Guided Therapy in Cirrhotic Patients With Esophagogastric Varices
- The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT
- Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
- Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis
- Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection
- Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
- A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
- To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
- Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
- ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis
- A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
- Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices
- Surrogate Markers of Portal Pressure
- A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
- TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
- Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)
- Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
- Metformin Experience on Minimal Hepatic Encephalopathy
- To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock
- To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.
- To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis
- Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis
- Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension
- Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study
- Alfapump-albumin Replacement Therapy
- Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
- Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
- Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
- Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection
- Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
- The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
- The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding
- IBAT Inhibitor A4250 for Cholestatic Pruritus
- Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
- Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis
- Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
- Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients
- An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
- Primary Prevention Hepatocellular Carcinoma by Metformin
- Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
- Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
- Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study
- Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
- A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
- A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients
- A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASH
- Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
- To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
- A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)
- A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions
- Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation
- Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV
- Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated Cirrhosis
- Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance
- A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension
- A Study of IDN-6556 in Subjects With Liver Cirrhosis
- Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
- Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C
- Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
- Baclofen in the Treatment of Muscle Cramps in Patients With Cirrhosis
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
- A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infectio
- Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis
- Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
- Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis
- An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
- Pilot Study of FFP104 Dose Escalation in PBC Subjects
- Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial
- Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis
- Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot Study
- A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
- Simvastatin Effect on Portal Hypertension
- Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
- Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis
- Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis
- Rifaximin Predicts the Complications of Decompensated Cirrhosis
- Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis
- Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
- Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study
- Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
- A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial
- Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
- A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis
- Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Viru
- Optimized Treatment and Regression of HBV-induced Early Cirrhosis
- Optimized Treatment and Regression of HBV-induced Liver Fibrosis
- Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
- Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
- Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis
- Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis
- Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
- A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
- Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients
- New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
- Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
- Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
- Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
- Quality of Life and Nutritional Improvements in Cirrhotic Patients
- Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
- Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis
- Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
- Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial
- Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
- Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
- Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant
- L-ornithine L-aspartate in Overt Hepatic Encephalopathy
- Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis
- Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
- A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compens
- VSL#3 and Spontaneous Bacterial Peritonitis
- Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis
- Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
- Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
- An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension
- Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
- Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
- Probiotics for Liver Cirrhosis With Portal Hypertension
- Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
- Effect of Tolvaptan on Cognitive Function in Cirrhosis
- Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
- Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
- Keyhole Limpet Hemocyanin in Chronic Hepatitis C
- Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis
- Treatment of Muscle Cramps in Patients With Liver Cirrhosis
- Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
- Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
- Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation
- Proton Pump Inhibitors and Dysbiosis in Cirrhosis
- Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension
- The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
- Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
- Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
- Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
- Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric Varices
- Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study
- A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
- Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
- Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
- Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis
- Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis
- Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
- Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
- Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis
- Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
- A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
- A Randomized Trial of GVS Alone vs. Propranolol
- Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis
- Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
- Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
- Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis
- Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension
- A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis
- Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC
- Pentoxifylline for Primary Biliary Cirrhosis
- Mesenchymal Stem Cells Treat Liver Cirrhosis
- Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
- Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
- Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis
- Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
- A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
- Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis
- Early Primary Prophylaxis of Esophageal Varices
- Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
- Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
- Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
- Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
- Probiotics for Portal Hypertension
- Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment
- Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
- Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
- Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure
- Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
- A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
- Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein
- Effect of Candesartan in Alcoholic Liver Fibrosis
- Propofol Versus Midazolam and Fentanyl for Diagnostic and Screening Colonoscopy in Patients With Advanced Liver Disease
- Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.
- Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
- Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis
- Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
- A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis
- Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis
- Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
- Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
- Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin
- Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers
- Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers
- Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
- Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
- Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)
- Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
- Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.
- Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT)
- Rifaximin Versus Lactulose in Renal Failure
- Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
- Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal Syndrome
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
- Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
- Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function
- Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)
- Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial
- Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis
- Terlipressin in Septic Shock in Cirrhosis
- Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
- A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients
- Moexipril for Primary Biliary Cirrhosis
- Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
- Use of Fenofibrate for Primary Biliary Cirrhosis
- Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
- Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis
- Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding
- A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis
- Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
- Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
- TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis
- Efficacy of Baclofen in the Treatment of Alcohol Addiction
- Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
- Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
- Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
- Satavaptan Dose-Ranging Study in the Prevention of Ascites
- Study of Combivir for Patients With Primary Biliary Cirrhosis
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
- Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
- Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371)
- Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)
- Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
- Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
- Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis
- Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
- Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
- Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis
- Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis
- Banding Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
- Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
- Probiotics for the Prevention of Major Complications of Cirrhosis
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
- Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis
- Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C
- Steroid Free Immunosuppression in Liver Transplantation
- Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin
- Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
- A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.
- Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
- DOCICAR: Cardiac Dysfunction in Cirrhosis
- Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects
- Development of a Breath Test for Monitoring Patients With Liver Disease
- Prevention of Decompensation in Liver Cirrhosis
- Selenium Supplementation of Patients With Cirrhosis
- Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection
- Study of Long-term Peg Intron vs. Colchicine in Non-responders.
- Urotensin II and Vascular Tone in Cirrhosis
- Clinical Trial of Pentoxifylline in Patient With Cirrhosis
- Use of NovoSeven® in Active Variceal Bleeding
- Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer
- SAMe to Treat Biliary Cirrhosis Symptoms
- Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
- Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C
- Efficacy and Safety of Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
- Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
- Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
- Treatment of Cholestatic Pruritus With Sertraline
- Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
- PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)
- Prevention of Esophageal Varices by Beta-Adrenergic Blockers
- Ursodiol-Methotrexate for Primary Biliary Cirrhosis
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment
- Role of Nitric Oxide in Cirrhosis: Relationship With Systemic Hemodynamics, Renal Function, Vasoactive Systems and Endotoxemia
- Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
- Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
- Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
- Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
- Prevention of Esophageal Varices by Beta-Adrenergic Blockers
- Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis